Skip to main content
PolicySpeak
← All files
RP

Royal Philips

Company · Netherlands · EU Transparency Register 035366013790-68

7
positions filed
in the 326 files tracked
7
legislative files
of 326 tracked
7
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #82 by legislative files engaged — a count of participation, not a measure of influence.

4.8
declared lobbying FTE
self-declared
€1.3M+
declared costs / yr (floor)
4
EP accreditations
as declared to the register
2014
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Registered as
Koninklijke Philips (Philips)
Head office
Amsterdam, Netherlands
EU office
Brussels

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Royal in PolicySpeak: request access →

Work at Royal Philips? so we know who speaks for it.

Follow the files Royal Philips engages with

One email on Tuesdays when a new position is filed on these 7 files, from Royal Philips or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Royal Philips filed 7 positions between 7 Mar 2025 and 19 May 2026, across 7 of the 326 legislative files tracked here, attaching a full position paper 7 times.

2025 · 4 filed2026 · 3 filed

What they argued

Circular Economy Actfiled 16 Oct 2025PDFsource

As a global health tech leader, Philips is committed to do what it takes to drive environmental impact and transition to a circular economy. A circular way of doing business can contribute to long-term economic growth, coupled with care for our planet and society.

Evaluation of the Public Procurement Directivesfiled 7 Mar 2025PDFsource

Many thanks for the opportunity to provide our feedback. You find here attached our recommendations for a revision of the Public Procurement Directive, as well as the overall framework for procurement of medical and digital health technologies in the European Union.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025PDFsource

Thank you for the opportunity to comment on the targeted revision of the EU rules for medical devices. Philips shares the concerns as raised in the call for evidence. We believe a reform of the regulatory framework is necessary to ensure availability of medical devices for patients and to strenghten EU competitiveness. The announced revision is an important pilar of the EU Life Science Strategy.

Revision of EU rules on public procurementfiled 21 Jan 2026PDFsource

Public procurement plays a critical role in addressing health systems' challenges through strategic purchasing decisions that focus on the value a given solution brings to the broader healthcare system. It can also be a powerful tool to drive innovation and the competitiveness of European industry.

EU taxonomy - Review of the environmental delegated actfiled 14 Apr 2026PDFsource

We appreciate the efforts of the European Commission to simplify the taxonomy and welcome several of the proposed changes. However, we are still concerned that some of the criteria in this draft delegated act will exclude entire sub-sectors of electric and electronic equipment, including and especially manufacture of electro-medical equipment (medical devices), from alignment with the EU Taxonomy.

Health Checks for Cardiovascular diseasesfiled 19 May 2026PDFsource

Thank you for the opportunity to contribute to the EU CVD Health Check Protocol. Philips strongly supports the European Commissions commitment to reducing premature mortality from cardiovascular diseases (CVD) across the EU by 2030. We recognize that the development and implementation of a comprehensive EU Protocol on Health Checks is a critical step toward achieving this ambitious and vital public health objective.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 320.

Is this your organization?

Everything on this page comes from Royal Philips’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.